Breast cancer patients' attitudes about rationing postlumpectorny radiation therapy: Applicability of trade-off methods to policy-making

Journal of Clinical Oncology

Volumn 15, Issue 10, 1997, Pages 3192-3200

  Palda, Valerie A ^a   Llewellyn Thomas, Hilary A ^a   Mackenzie, Robert G ^a   Pritchard, Kathleen I ^a   Naylor, C David ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; HEALTH CARE POLICY; HUMAN; MEDICAL DECISION MAKING; PARTIAL MASTECTOMY; PATIENT ATTITUDE; PATIENT SELECTION; PRIORITY JOURNAL; RESOURCE ALLOCATION; TREATMENT INDICATION;

EID: 0030929064     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.10.3192     Document Type: Article

References (51)

1. Hughes TE, Larson LN: Patient involvement in health care. A procedural justice viewpoint. Med Care 29:297-303, 1991
2. Sutherland HJ, Llewellyn-Thomas HA, Lockwood G, et al: Cancer patients: Their desire for information and participation in treatment decisions. J R Soc Med 82:260-263, 1989
3. Brody DS: The patient's role in clinical decision-making. Ann Intern Med 93:718-722, 1980
4. Cassileth BR, Zupkis RV, Sutton-Smith K, et al: Information and participation preferences among cancer patients. Ann Intern Med 92:832-836, 1980
5. Cassileth BR, Volckmar BA, Goodman RL: The effect of experience on radiation therapy patients' desire for information. Int J Radiat Oncol Biol Phys 6:493-496, 1980
6. Whelan TJ, Levine MN, Gafni A, et al: Breast irradiation post-lumpectomy: Development and evaluation of a decision instrument. J Clin Oncol 13:847-853, 1995
7. Levine MN, Gafni A, Markham B, et al: A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med 117:53-58, 1992
8. Llewellyn-Thomas HA: Patient's health care decision making: A framework for descriptive and experimental investigations. Med Decis Making 15:101-106, 1995
9. O'Connor AM: Validation of a decisional conflict scale. Med Decis Making 15:25-30, 1995
10. Nord E, Richardson J, Macarounas-Kirchmann K: Social evaluation of health care versus personal evaluation of health states. Int J Technol Assess Health Care 9:463-478, 1993
11. Richardson WS, Detsky AS: Users' guides to the medical literature: VII. How to use a clinical decision analysis. A. Are the results of the study valid? JAMA 273:1292-1295, 1995
12. Richardson WS, Detsky AS: Users' guides to the medical literature: VII. How to use a clinical decision analysis. B. What are the results and will they help me in caring for my patients? JAMA 273:1610-1613, 1995
13. Pater JL, Brundage MD, Goodwin PJ, et al: Outcome measures in Oncology. Ann R Coll Phys Surg Can 27:175-178, 1994
14. Naylor CD, Llewellyn-Thomas HA: Can there be a more patient-centred approach to determining clinically important effect sizes for randomized treatment trials? J Clin Epidemiol 47:787-795, 1994
15. Llewellyn-Thomas HA, Williams JI, Levy L, et al: Using a trade-off technique to assess patients' treatment preferences for benign prostatic hyperplasia. Med Decis Making 16:262-272, 1996
16. Llewellyn-Thomas HA, Williams JI, Arshinoff R: Patients' "maximal acceptable time" waiting for total joint replacement. Theoret Surg 9:184, 1994 (abstr)
17. Llewellyn-Thomas HA, Thiel EC, Naylor CD: Waiting for elective CABG: Patients' perceived risks and utilities for time. Med Decis Making 12:337, 1992 (abstr)
18. O'Connor AM, Boyd NF, Warde P, et al: Eliciting preference for alternative drug therapies in oncology: Influence of treatment outcome description, elicitation technique and treatment experience on preferences. J Chronic Dis 40:811-818, 1987
19. O'Connor AM: Effects of framing and level of probability on patients' preferences for cancer chemotherapy. J Clin Epidemiol 42:119-126, 1989
20. Llewellyn-Thomas HA, Thiel EC, Clark RM: Patients versus surrogates: Whose opinion counts on ethics review panels? Clin Res 37:501-505, 1989
21. Percy ML, Llewellyn-Thomas HA: Assessing preferences about the DNR order: Does it depend on how you ask? Med Decis Making 15:209-216, 1995
22. Mackillop WJ, Fu H, Quirt CF, et al: Waiting for radiation therapy in Ontario. Int J Radiat Oncol Biol Phys 30:221-228, 1994
23. Veronesi U, Saccozzi R, Del Vecchio M, et al: Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiation therapy in patients with small cancers of the breast. N Engl J Med 305:6-11, 1981
24. Sarrazin D, Le MG, Arriagada R, et al: Ten year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 14:177-184, 1989
25. van Dongen JA, Bartelink H, Fentiman IS, et al: A randomized clinical trial to assess the value of breast conserving therapy in stage I and II breast cancer, EORTC 10801 trial, in National Institutes of Health Consensus Development Conference on the Treatment of Early-Stage Breast Cancer. NCI Monogr 11:15-18, 1992
26. Lichter AS, Lippman ME, Danforth DN, et al: Mastectomy versus breast-conserving therapy in the treatment of Stage I and II carcinoma of the breast: A randomized trial at the National Cancer Institute. J Clin Oncol 10:976-983, 1992
27. Blichert-Toft M: A Danish randomized trial comparing breast preservation with mastectomy in mammary carcinoma. Proceedings of the National Institutes of Health Consensus Development Conference on Early Stage Breast Cancer 1990, pp 28-31
28. Fisher B, Bauer M, Margolese R, et al: Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312:665-673, 1985
29. Uppsala-Orebro Breast Cancer Study Group: Sector resection with or without postoperative radiation therapy for stage I breast cancer: A randomized trial. J Natl Cancer Institute 82:277-282, 1990
30. Clark RM, McCullough PB, Levine MN, et al: Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84:683-689, 1992
31. Veronesi U, Luini A, Del Vecchio M, et al: Radiation therapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 28:1587-1591, 1993
32. Sutcliffe S: Radiation treatment services: More, how, what cost? Can J Oncol 3:III, 1993 (editorial)
33. Craighead PS, Ewing GH: Compromise in radiation therapy facilities: Local response to a nationwide problem. Can J Oncol 3:193-199, 1993
34. Redelmeier DA, Rozin P, Kahneman D: Understanding patients' decisions: Cognitive and emotional perspectives. JAMA 270:72-76, 1993
35. Wolfe SD, Llewellyn-Thomas HA: Assessing in-vitro fertilization preferences: Trading off risks and benefits. Med Decis Making 12:322, 1991 (abstr)
36. Mazur DJ, Merz JF: How the manner of presentation of data influences older patients in determining their treatment preferences. J Am Geriatr Soc 41:223-228, 1993
37. Llewellyn-Thomas HA, McGreal MJ, Thiel EC, et al: Patients' willingness to enter clinical trials: Measuring the association with perceived benefit and preference for decision participation. Soc Sei Med 32:35-42, 1991
38. Sackett DL, Torrance GW: The utility of different health states as perceived by the general public. J Chronic Dis 31:697-704, 1978
39. Rosser R, Kind P: A scale of valuations of states of illness: Is there a social consensus? Int J Epidemiol 7:347-358, 1978
40. Boyd NF, Sutherland HJ, Heasman KZ, et al: Whose utilities for decision analysis? Med Decis Making 10:58-67, 1990
41. Llewellyn-Thomas HA, Thiel EC, McGreal MJ: Patients' evaluations of their current health state: The influence of expectations, comparisons, and actual health status. Med Decis Making 121:115-122, 1992
42. The Health Services Research Group: Studying patients' preferences in health care decision making. Can Med Assoc J 147:859-864, 1992
43. Coates AS, Simes RJ: Patient assessment of adjuvant treatment in operable breast cancer, in Williams CJ (ed): Introducing New Treatments for Cancer: Practical, Ethical, and Legal Problems. New York, NY, Wiley, 1992 pp 447-458
44. Samuelson W, Zeckhauser R: Status quo bias in decision making. J Risk Uncertainty 1:7-59, 1988
45. Man-Son-Hing M, Laupacis A, O'Connor A, et al: Warfarin for atrial fibrillation: The patient's perspective. Arch Intern Med 156:1841-1848, 1996
46. Lenert LA, Flowers C, Goldstein MK, et al: Effect of method for search for subjects' indifference point on the reliability and validity of standard gamble utilities. Med Decis Making 15:430, 1995 (abstr)
47. Atrial Fibrillation Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 154:1449-1457, 1994
48. GUSTO investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329:673-682, 1993
49. Smith GD, Sing F, Sheldon TA: Cholesterol lowering and mortality: The importance of considering initial level or risk. BMJ 306:1367-1373, 1993
50. Naylor CD: Grey zones of clinical practice: Some limits to evidence-based medicine. Lancet 345:840-842, 1995
51. Official Report: Health Canada 1993 National Forum on Breast Cancer. Ottawa, Canada, Supplies and Services Canada, 1993